-
Dr. Jie Li: Exploring and Prospects of Functional Cure for Chronic Hepatitis B
1. HBsAg Clearance Significantly Reduces the Risk of HCC and End-Stage Liver Disease in CHB Patients A study in Chinese Taiwan recruited patients with CHB-related liver cirrhosis who achieved virological…
-
Can Expired Blood Culture Bottles Still Be Used?
In resource-limited settings, the use of medical equipment is often restricted by expiration dates and storage conditions. However, new research conducted by the Institute of Tropical Medicine (ITM) in Antwerp,…
-
Dr. Yue Lu: A Review and Update on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), a rare malignancy of the hematopoietic system, is distinguished by its highly recognizable skin manifestations and complex pathophysiology, which continue to captivate the medical community’s investigative spirit and challenge its resolve. Recently, Dr. Yue Lu from Lu Daopei Medical provided an in-depth analysis of BPDCN’s origins, clinical presentation, diagnostic…
-
Mutual Learning Between China and Germany丨International Perspectives, Leading the Frontier: The Academic Journey of Dr. Jürgen Wolf from the Universit
With an international perspective and a focus on leading-edge advancements, the Overseas Experts China Tour project welcomed a prominent figure in the field of lung cancer from August 5th to 10th, 2024—Dr. Jürgen Wolf, Director of the Centre for Integrated Oncology (CIO) at University Hospital of Cologne, Professor of Interdisciplinary Translational Oncology at the University…
-
Dr. Zhizhong Pan: The Journey of Colorectal Cancer Immunotherapy Research—Experiences from Sun Yat-sen University Cancer Center丨Guangzhou Colorectal Cancer Summit Forum
At the Guangzhou Colorectal Cancer Summit Forum and the 22nd Guangdong Colorectal Cancer Academic Conference held from August 5-10, 2024, Dr. Zhizhong Pan from Sun Yat-sen University Cancer Center delivered an insightful presentation titled “The Journey of Colorectal Cancer Immunotherapy Research: Experiences from Sun Yat-sen University Cancer Center.” After the conference, Professor Pan granted us…
-
Insights from Hematology Expert | Dr. Jianxiang Wang: Delving into Immune Mechanisms to Pioneer New Target Frontiers
The breakthrough achievements of CAR-T therapy in the field of hematologic malignancies are remarkable. However, challenges such as target limitations, limited cell sources, and durability of efficacy continue to necessitate further exploration. Dr. Jianxiang Wang’s team at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences , stands as a pioneer…
-
Dr. Ruiyun Zhang: New Approaches Like Targeted Immunotherapy and ctDNA Further Address the Bladder-Preserving Needs of MIBC Patients | 2024 ASCOBT
The ASCO Breakthrough Summit, held from August 8th to 10th in Yokohama, Japan, focused on new technologies in cancer treatment and shared breakthrough advances and research that are driving global cancer treatment forward. The research titled “Preliminary results of an open-label, single-arm, multi-center study on disitamab vedotin (DV) combined with toripalimab and radiotherapy as bladder-preserving…
-
IDWeek: Management of Novel Beta-Lactam Antibiotics
Editor’s Note: The Infectious Disease Week (IDWeek) in the United States is a premier global academic conference in the field of infectious diseases. It gathers nearly 10,000 experts and scholars…
Connecting Medical Expertise through Media